Morgan Stanley
GRDN

Morgan Stanley’s Guardian Pharmacy Services GRDN Stock Holding History

Morgan Stanley’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.41M Sell
116,968
-29,283
-20% -$957K ﹤0.01% 4233
2025
Q4 		$4.4M Sell
146,251
-12,624
-8% -$357K ﹤0.01% 4276
2025
Q3 		$4.17M Buy
158,875
+125,908
+382% +$3M ﹤0.01% 4292
2025
Q2 		$703K Buy
32,967
+16,947
+106% +$382K ﹤0.01% 5287
2025
Q1 		$341K Sell
16,020
-6,411
-29% -$132K ﹤0.01% 5511
2024
Q4 		$454K Buy
22,431
+22,055
+5,866% +$455K ﹤0.01% 5460
2024
Q3 		$6.32K Buy
+376
New +$6.34K ﹤0.01% 6845

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley's GRDN Position: Q1 2026 in Review

Morgan Stanley reduced its Guardian Pharmacy Services (GRDN) stake by 20% in Q1 2026, selling an estimated $957K and leaving 116,968 shares worth $4.41M. The position accounts for ﹤0.01% of the portfolio, ranked #4233.

Morgan Stanley first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Morgan Stanley held 116,968 shares of Guardian Pharmacy Services worth $4.41M as of Q1 2026.
  • Morgan Stanley sold 29,283 Guardian Pharmacy Services shares in Q1 2026, an estimated $957K.
  • Guardian Pharmacy Services made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4233 holding.
  • Morgan Stanley first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.